Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer

Vincenza Conteduca; Simon J. Crabb; Robert J. Jones; Orazio Caffo; Tony Elliott; Emanuela Scarpi; Paolo Fabbri; Lisa Derosa; Francesco Massari; Gianmauro Numico; Sunnya Zarif; Catherine Hanna; Francesca Maines; Helen Joyce; Cristian Lolli; Ugo De Giorgi

doi:10.1371/journal.pone.0158952

Loading metrics

Open Access

Peer-reviewed

Research Article

Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer

Vincenza Conteduca,

Affiliation Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy
⨯
Simon J. Crabb,

Affiliation Cancer Sciences Unit, University of Southampton, Southampton, United Kingdom
⨯
Robert J. Jones,

Affiliation Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
⨯
Orazio Caffo,

Affiliation Medical Oncology Department - Santa Chiara Hospital, Trento, Italy
⨯
Tony Elliott,

Affiliation Christie Hospital, Manchester, United Kingdom
⨯
Emanuela Scarpi,

Affiliation Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy
⨯
Paolo Fabbri,

Affiliation Oncology Unit, Cervesi Hospital, Cattolica, Italy
⨯
Lisa Derosa,

Affiliation Medical Oncology Department - Santa Chiara Hospital, Pisa, Italy
⨯
Francesco Massari,

Affiliation Institut Gustave Roussy, Villejuif, France
⨯
Gianmauro Numico,

Affiliation Medical Oncology and Hematology, Azienda USL della Valle d’Aosta, Aosta, Italy
⨯
Sunnya Zarif,

Affiliation Cancer Sciences Unit, University of Southampton, Southampton, United Kingdom
⨯
Catherine Hanna,

Affiliation Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
⨯
Francesca Maines,

Affiliation Medical Oncology Department - Santa Chiara Hospital, Trento, Italy
⨯
Helen Joyce,

Affiliation Christie Hospital, Manchester, United Kingdom
⨯
Cristian Lolli,

Affiliation Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy
⨯
[ ... ],
Ugo De Giorgi

* E-mail: ugo.degiorgi@irst.emr.it

Affiliation Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy
⨯
[ view all ]
[ view less ]

Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer

Vincenza Conteduca,
Simon J. Crabb,
Robert J. Jones,
Orazio Caffo,
Tony Elliott,
Emanuela Scarpi,
Paolo Fabbri,
Lisa Derosa,
Francesco Massari,
Gianmauro Numico

Published: July 19, 2016
https://doi.org/10.1371/journal.pone.0158952

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Receptor antagonist therapy
Is the Subject Area "Receptor antagonist therapy" applicable to this article?

Thanks for your feedback.
Lymphocytes
Is the Subject Area "Lymphocytes" applicable to this article?

Thanks for your feedback.
Neutrophils
Is the Subject Area "Neutrophils" applicable to this article?

Thanks for your feedback.
Corticosteroid therapy
Is the Subject Area "Corticosteroid therapy" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.